Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Laiterä, Tiina ^a,b   Sarajärvi, Timo ^a   Haapasalo, Annakaisa ^a   Puli, Lakshman ^a   Kauppinen, Tarja ^a   Mäkinen, Petra ^a   Rauramaa, Tuomas ^a,b   Tanila, Heikki ^a   Jääskeläinen, Juha E ^a,b   Alafuzoff, Irina ^c   Soininen, Hilkka ^a,b   Leinonen, Ville ^a,b   Hiltunen, Mikko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; GAMMA SECRETASE; SECRETASE;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BRAIN BIOPSY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NORMOTENSIVE HYDROCEPHALUS; FRONTAL LOBE; METABOLISM; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; FEMALE; FRONTAL LOBE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MALE;

EID: 84899116559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093717     Document Type: Article

References (31)

1. Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2: 307-327.
2. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57: S4-16; discussion ii-v.
3. Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Sutela A, et al. (2012) Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 38: 72-86.
4. Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Tamminen JN, et al. (2010) Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease. Ann Neurol 68: 446-453.
5. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59: 1381-1389. (Pubitemid 35014802)
6. Yang LB, Lindholm K, Yan R, Citron M, Xia W, et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9: 3-4. (Pubitemid 36098241)
7. Ahmed RR, Holler CJ, Webb RL, Li F, Beckett TL, et al. (2010) BACE1 and BACE2 enzymatic activities in Alzheimer's disease. J Neurochem 112: 1045-1053.
8. Kakuda N, Shoji M, Arai H, Furukawa K, Ikeuchi T, et al. (2012) Altered gamma-secretase activity in mild cognitive impairment and Alzheimer's disease. EMBO Mol Med 4: 344-352.
9. Liu F, Xue ZQ, Deng SH, Kun X, Luo XG, et al. (2013) Gamma-secretase binding sites in aged and Alzheimer's disease human cerebrum: The choroid plexus as a putative origin of CSF Abeta. Eur J Neurosci 37: 1714-1725.
10. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, et al. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
11. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112: 389-404. (Pubitemid 44469160)
12. Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B, et al. (2003) Partial purification and characterization of gamma-secretase from postmortem human brain. J Biol Chem 278: 24277-24284. (Pubitemid 37548577)
13. Seppala TT, Nerg O, Koivisto AM, Rummukainen J, Puli L, et al. (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78: 1568-1575.
14. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of alzheimer's abeta peptide: The many roads to perdition. Neuron 43: 605-608. (Pubitemid 39179722)
15. Natunen T, Parrado AR, Helisalmi S, Pursiheimo JP, Sarajarvi T, et al. (2013) Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease. J Alzheimers Dis 37: 217-232.
16. Pluta R (2007) Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain. Curr Neurovasc Res 4: 121-129.
17. de la Torre JC (2008) Alzheimer's disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis 14: 353-359.
18. Li L, Zhang X, Yang D, Luo G, Chen S, et al. (2009) Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol Aging 30: 1091-1098.
19. Tabaton M, Tamagno E (2007) The molecular link between beta- and gamma-secretase activity on the amyloid beta precursor protein. Cell Mol Life Sci 64: 2211-2218. (Pubitemid 47347960)
20. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, et al. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3: 85-97. (Pubitemid 34778398)
21. Tanimukai H, Imaizumi K, Kudo T, Katayama T, Tsuda M, et al. (1998) Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Brain Res Mol Brain Res 54: 212-218. (Pubitemid 28171785)
22. De Gasperi R, Sosa MA, Dracheva S, Elder GA (2010) Presenilin-1 regulates induction of hypoxia inducible factor-1alpha: Altered activation by a mutation associated with familial Alzheimer's disease. Mol Neurodegener. doi: 10.1186/1750-1326-5-38.
23. Goutte C, Tsunozaki M, Hale VA, Priess JR (2002) APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci U S A 99: 775-779. (Pubitemid 34106586)
24. Vassar R, Kovacs DM, Yan R, Wong PC (2009) The beta-secretase enzyme BACE in health and Alzheimer's disease: Regulation, cell biology, function, and therapeutic potential. J Neurosci 29: 12787-12794.
25. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, et al. (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282: 10873-10880. (Pubitemid 47100783)
26. Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW (2004) Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009: 1-8. (Pubitemid 38553842)
27. Sun X, He G, Qing H, Zhou W, Dobie F, et al. (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103: 18727-18732. (Pubitemid 44913478)
28. de Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, et al. (1983) Positron emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol 4: 568-571.
29. Haapasalo A, Kovacs DM (2011) The many substrates of presenilin/gamma- secretase. J Alzheimers Dis 25: 3-28.
30. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522.
31. Imbimbo BP, Giardina GA (2011) Gamma-secretase inhibitors and modulators for the treatment of Alzheimer's disease: Disappointments and hopes. Curr Top Med Chem 11: 1555-1570.